As sales of Incyte Corp.'s approved JAK inhibitor Jakafi (ruxolitinib) begin to pick up steam, a competing myelofibrosis candidate from Sanofi SA moved a step closer to market. more »

Like the troll of yore demanding his pound of goat flesh as the toll for using his bridge, patent trolls are threatening to swallow up biotech start-ups – just as they have other businesses that strayed too close to the vague boundary lines of their intellectual property. more »

The American Society of Clinical Oncology (ASCO) released the first of more than 4,700 abstracts late Wednesday in anticipation of its 2013 annual meeting, scheduled to attract more than 30,000 participants to Chicago from May 31 to June 4. more »


By any measurement the U.S. biotechnology industry is the envy of the world. Perspectives on the reasons for the nation's dominance in this sector are provided by the latest Scientific American Worldview Scorecard, which for the past five years has been ranking countries on their global competitiveness in biotechnology. The 2013 edition reflects increased global competition and a growing list of countries being added to the rankings.
Embryonic stem cells have been the subject of so many political fights that it's easy to forget they have also faced formidable scientific obstacles.
But they have. Human eggs, it turns out, are far more fragile than those of most other mammals including those of other primates. And so, methods that have been used to clone mammals from Dolly the sheep to Snuppy, the cloned dog that was South Korean stem cell scientist Woo-Suk Hwang's only non-fraudulent claim to fame, have failed to produce therapeutically cloned human embryonic stem cells. Until now.
READ MORE »- Sepsis Patients May Need Bigger Immune Response »
- No Working Kinase, but ErbB3 Acquires Oncogenic Mutations »
- Fungal Protein Points Way to New Breast Cancer Treatments »
- Short-lived Stem Cells Fight Brain Tumors, for a Time »
- Exhausted T Cells Can Rally Given Right Circumstances »
- Study Highlights New Target for Antidepressant Therapy »
- Adult Neurons Can Learn New Neurotransmitter 'Languages' »
- Study Could Lead to Inhibitors for Multidrug Molecular Pump »
- Weakened, Radioactive Listeria Poison Metastases, Not the Gut »

- Biotech’s White Knight (aka Serial Cheater) Gets Prison Time, FinallyMay 03, 2013 | 3:41 PM | Posted by: Lynn Yoffee
- Where’s Superman When He’s Needed?April 30, 2013 | 10:07 AM | Posted by: Mari Serebrov
- Biopeople to Meet at BIO2013: Inside the World of Biotech’s Luminaries, Titans and BrainiacsApril 19, 2013 | 8:38 AM | Posted by: Lynn Yoffee
- Cancer Research Through Time: Cure Should’ve Been Wrapped up by 1985April 08, 2013 | 11:50 AM | Posted by: Anette Breindl
- ‘ImaginAb’ That! BioWorld Salutes ‘Overall Awesomeness’April 01, 2013 | 1:46 PM | Posted by: Jennifer Boggs
Cast Your Vote
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST


